{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T01:11:00Z","timestamp":1778634660156,"version":"3.51.4"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007128","name":"Shaanxi Province Natural Science Foundation","doi-asserted-by":"publisher","award":["2021SF-179"],"award-info":[{"award-number":["2021SF-179"]}],"id":[{"id":"10.13039\/501100007128","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013317","name":"Shanxi Provincial Key Research and Development Project","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013317","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015401","name":"Key Research and Development Projects of Shaanxi Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015401","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["71904155"],"award-info":[{"award-number":["71904155"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002412","name":"Xi'an Jiaotong University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002412","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.ijcard.2022.10.015","type":"journal-article","created":{"date-parts":[[2022,10,10]],"date-time":"2022-10-10T12:16:00Z","timestamp":1665404160000},"page":"420-426","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Cost-effectiveness analysis of screening for peripheral artery disease in patients with coronary artery disease in China: A Markov model"],"prefix":"10.1016","volume":"371","author":[{"given":"Yuanming","family":"Xing","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yulan","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luting","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zuyi","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2022.10.015_bb0005","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.119.007385","article-title":"Polyvascular disease: reappraisal of the current clinical landscape","volume":"12","author":"Gutierrez","year":"2019","journal-title":"Circ. Cardiovasc. Interv."},{"key":"10.1016\/j.ijcard.2022.10.015_bb0010","doi-asserted-by":"crossref","first-page":"e1020","DOI":"10.1016\/S2214-109X(19)30255-4","article-title":"Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis","volume":"7","author":"Song","year":"2019","journal-title":"Lancet Glob. Health"},{"key":"10.1016\/j.ijcard.2022.10.015_bb0015","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1016\/j.jacc.2016.03.524","article-title":"Ticagrelor for prevention of ischemic events after myocardial infarction in patients with peripheral artery disease","volume":"67","author":"Bonaca","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2022.10.015_bb0020","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.5239","article-title":"Polyvascular disease and risk of major adverse cardiovascular events in peripheral artery disease: a secondary analysis of the EUCLID Trial","volume":"1","author":"Gutierrez","year":"2018","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.ijcard.2022.10.015_bb0025","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1016\/j.jacc.2016.11.007","article-title":"2016 AHA\/ACC guideline on the management of patients with lower extremity peripheral artery disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"69","author":"Gerhard-Herman","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2022.10.015_bb0030","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/eurheartj\/ehx095","volume":"39","author":"Aboyans","year":"2018","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2022.10.015_bb0035","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0140-6736(17)32458-3","article-title":"Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial","volume":"391","author":"Connolly","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2022.10.015_bb0040","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0140-6736(17)32409-1","article-title":"Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial","volume":"391","author":"Anand","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2022.10.015_bb0045","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1161\/CIRCRESAHA.121.318535","article-title":"Epidemiology of peripheral artery disease and polyvascular disease","volume":"128","author":"Aday","year":"2021","journal-title":"Circ. Res."},{"key":"10.1016\/j.ijcard.2022.10.015_bb0050","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s40261-021-01023-8","article-title":"Cost-effectiveness analysis of rivaroxaban plus aspirin compared with aspirin alone in patients with coronary and peripheral artery diseases in Italy","volume":"41","author":"Ferrara","year":"2021","journal-title":"Clin. Drug Investig."},{"key":"10.1016\/j.ijcard.2022.10.015_bb0055","first-page":"492","article-title":"Diagnostic value of ankle-brachial index in peripheral arterial disease: a meta-analysis","volume":"29","author":"Xu","year":"2013","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.ijcard.2022.10.015_bb0060","series-title":"China Guidelines for Pharmacoeconomic Evaluations","author":"Liu","year":"2020"},{"key":"10.1016\/j.ijcard.2022.10.015_bb0065","doi-asserted-by":"crossref","DOI":"10.7189\/jogh.09.010601","article-title":"National and subnational estimation of the prevalence of peripheral artery disease (PAD) in China: a systematic review and meta-analysis","volume":"9","author":"Song","year":"2019","journal-title":"J. Glob. Health"},{"key":"10.1016\/j.ijcard.2022.10.015_bb0070","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.jacc.2011.02.074","volume":"58","author":"Min","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2022.10.015_bb0075","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/0735-1097(94)90596-7","article-title":"Long-term survival in patients with coronary artery disease: importance of peripheral vascular disease. The Coronary Artery Surgery Study (CASS) Investigators","volume":"23","author":"Eagle","year":"1994","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2022.10.015_bb0080","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3724\/SP.J.1263.2011.00031","article-title":"Medical comorbidities at admission is predictive for 30-day in-hospital mortality in patients with acute myocardial infarction: analysis of 5161 cases","volume":"8","author":"Yang","year":"2011","journal-title":"J. Geriatr. Cardiol."},{"key":"10.1016\/j.ijcard.2022.10.015_bb0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0166069","article-title":"External validation of a case-mix adjustment model for the standardized reporting of 30-Day stroke mortality rates in China","volume":"11","author":"Yu","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ijcard.2022.10.015_bb0090","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1161\/STROKEAHA.113.002977","article-title":"Impaired glucose regulation predicted 1-year mortality of Chinese patients with ischemic stroke: data from abnormal glucose regulation in patients with acute stroke across China","volume":"45","author":"Jia","year":"2014","journal-title":"Stroke"},{"key":"10.1016\/j.ijcard.2022.10.015_bb0095","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1136\/heartjnl-2020-317165","article-title":"Incidence, predictors, and prognostic impact of recurrent acute myocardial infarction in China","volume":"107","author":"Song","year":"2020","journal-title":"Heart"},{"key":"10.1016\/j.ijcard.2022.10.015_bb0100","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1056\/NEJMoa1709118","article-title":"Rivaroxaban with or without Aspirin in stable cardiovascular disease","volume":"377","author":"Eikelboom","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2022.10.015_bb0105","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.119.006399","article-title":"Incidence and factors associated with major amputation in patients with peripheral artery disease: insights from the EUCLID trial","volume":"13","author":"Long","year":"2020","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"key":"10.1016\/j.ijcard.2022.10.015_bb0110","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.ejvs.2021.02.039","article-title":"Clinical benefit, harm, and cost effectiveness of screening men for peripheral artery disease: a markov model based on the VIVA Trial","volume":"61","author":"Lindholt","year":"2021","journal-title":"Eur. J. Vasc. Endovasc. Surg."},{"key":"10.1016\/j.ijcard.2022.10.015_bb0115","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.ejvs.2015.10.022","article-title":"The risk of disease progression in peripheral arterial disease is higher than expected: a meta-analysis of mortality and disease progression in peripheral arterial disease","volume":"51","author":"Sigvant","year":"2016","journal-title":"Eur. J. Vasc. Endovasc. Surg."},{"key":"10.1016\/j.ijcard.2022.10.015_bb0120","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jchf.2013.12.003","article-title":"Impact of cardiovascular events on change in quality of life and utilities in patients after myocardial infarction: a VALIANT study (valsartan in acute myocardial infarction)","volume":"2","author":"Lewis","year":"2014","journal-title":"JACC Heart Fail."},{"key":"10.1016\/j.ijcard.2022.10.015_bb0125","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S1262-3636(07)70154-4","article-title":"Diabetic foot ulcers and amputations: estimates of health utility for use in cost-effectiveness analyses of new treatments","volume":"30","author":"Redekop","year":"2004","journal-title":"Diabetes Metab."},{"key":"10.1016\/j.ijcard.2022.10.015_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvs.2021.05.049","article-title":"Cost-effectiveness analysis of ankle-brachial index screening in patients with coronary artery disease to optimize medical management","volume":"74","author":"Minami","year":"2021","journal-title":"J. Vasc. Surg."},{"key":"10.1016\/j.ijcard.2022.10.015_bb0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0211493","article-title":"Health-related quality of life loss associated with first-time stroke","volume":"14","author":"Yeoh","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.ijcard.2022.10.015_bb0140","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.2165\/00019053-200624100-00009","article-title":"The cost effectiveness of anticoagulation management services for patients with atrial fibrillation and at high risk of stroke in the US","volume":"24","author":"Sullivan","year":"2006","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.ijcard.2022.10.015_bb0145","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/s12955-018-1019-3","article-title":"Health-related quality of life impact of minor and major bleeding events during dual antiplatelet therapy: a systematic literature review and patient preference elicitation study","volume":"16","author":"Doble","year":"2018","journal-title":"Health Qual. Life Outcomes"},{"key":"10.1016\/j.ijcard.2022.10.015_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinthera.2019.01.005","article-title":"Impact of optimal medical therapy at discharge on one-year direct medical costs in patients with acute coronary syndromes: a retrospective, observational database analysis in China","volume":"41","author":"He","year":"2019","journal-title":"Clin. Ther."},{"key":"10.1016\/j.ijcard.2022.10.015_bb0155","series-title":"China Health Statistics Yearbook 2020","article-title":"National Health Commission of the People's Republic of China","year":"2021"},{"key":"10.1016\/j.ijcard.2022.10.015_bb0160","article-title":"Economic burden of myocardial infarction combined with Dyslipidemia","volume":"9","author":"Chen","year":"2021","journal-title":"Front. Public Health"},{"key":"10.1016\/j.ijcard.2022.10.015_bb0165","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1161\/STROKEAHA.119.027980","article-title":"Cost-effectiveness of a multifaceted quality improvement intervention for Acute Ischemic stroke in China","volume":"51","author":"Pan","year":"2020","journal-title":"Stroke"},{"key":"10.1016\/j.ijcard.2022.10.015_bb0170","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ijcard.2020.06.016","article-title":"Analysis of 17 years of surgical treatment for chronic limb ischemia in a Chinese National Clinical Center for Geriatric Disorders (2002 to 2018)","volume":"318","author":"Guo","year":"2020","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2022.10.015_bb0175","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s10198-021-01384-z","article-title":"Estimation of the cost-effective threshold of a quality-adjusted life year in China based on the value of statistical life","volume":"23","author":"Cai","year":"2022","journal-title":"Eur. J. Health Econ."},{"key":"10.1016\/j.ijcard.2022.10.015_bb0180","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1177\/2047487318817910","article-title":"Cost-effectiveness of low-dose rivaroxaban and aspirin versus aspirin alone in people with peripheral or carotid artery disease: an Australian healthcare perspective","volume":"26","author":"Zomer","year":"2019","journal-title":"Eur. J. Prev. Cardiol."},{"key":"10.1016\/j.ijcard.2022.10.015_bb0185","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1056\/NEJMoa2000052","article-title":"Rivaroxaban in peripheral artery disease after revascularization","volume":"382","author":"Bonaca","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2022.10.015_bb0190","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1177\/1358863X17745371","article-title":"Cost-effectiveness analysis of asymptomatic peripheral artery disease screening with the ABI test","volume":"23","author":"Itoga","year":"2018","journal-title":"Vasc. Med."},{"issue":"1417\u201324","key":"10.1016\/j.ijcard.2022.10.015_bb0195","article-title":"Similarities and differences in peripheral artery disease between China and Western countries","volume":"74","author":"Gao","year":"2021","journal-title":"J. Vasc. Surg."},{"key":"10.1016\/j.ijcard.2022.10.015_bb0200","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1161\/CIRCRESAHA.121.318243","article-title":"Racial and ethnic disparities in peripheral artery disease","volume":"128","author":"Hackler","year":"2021","journal-title":"Circ. Res."},{"key":"10.1016\/j.ijcard.2022.10.015_bb0205","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1001\/jama.286.11.1317","article-title":"Peripheral arterial disease detection, awareness, and treatment in primary care","volume":"286","author":"Hirsch","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2022.10.015_bb0210","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ijcard.2018.10.047","article-title":"A national study of the prevalence and risk factors associated with peripheral arterial disease from China: the China Hypertension Survey, 2012-2015","volume":"275","author":"Wang","year":"2019","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2022.10.015_bb0215","doi-asserted-by":"crossref","first-page":"42S","DOI":"10.1016\/j.jvs.2014.12.008","article-title":"A systematic review for the screening for peripheral arterial disease in asymptomatic patients","volume":"61","author":"Alahdab","year":"2015","journal-title":"J. Vasc. Surg."},{"key":"10.1016\/j.ijcard.2022.10.015_bb0220","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1016\/S0140-6736(17)32250-X","article-title":"Population screening and intervention for vascular disease in Danish men (VIVA): a randomised controlled trial","volume":"390","author":"Lindholt","year":"2017","journal-title":"Lancet"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527322015248?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527322015248?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:13:26Z","timestamp":1778631206000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527322015248"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":44,"alternative-id":["S0167527322015248"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2022.10.015","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost-effectiveness analysis of screening for peripheral artery disease in patients with coronary artery disease in China: A Markov model","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2022.10.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}